InMed Pharmaceuticals (IMLFF) News Today $4.40 +0.26 (+6.25%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period InMed Pharmaceuticals Secures $10 Million Equity Purchase AgreementDecember 17, 2024 | markets.businessinsider.comInMed Pharmaceuticals Explores CBN for Skin Disease TreatmentNovember 20, 2024 | markets.businessinsider.comInMed Pharmaceuticals Inc trading halted, news pendingNovember 14, 2024 | markets.businessinsider.comInMed Pharmaceuticals to Consolidate Shares for Nasdaq ComplianceNovember 5, 2024 | markets.businessinsider.comInMed reports progress in Alzheimer's drug studyAugust 1, 2024 | investing.comInMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic AbilitiesMay 6, 2024 | benzinga.comInMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid AnalogDecember 11, 2023 | benzinga.comInMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital ConferenceOctober 18, 2023 | benzinga.comCannabisNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business UpdateMay 16, 2023 | marketwatch.comInMed Pharmaceuticals Stock Trading Higher On Q3 Sales Growth Of 234%, Here Is What You Need To KnowMay 16, 2023 | msn.comInMed Pharmaceuticals Stock (NASDAQ:INM), Short Interest ReportMarch 21, 2023 | benzinga.comINM InMed Pharmaceuticals Inc.January 21, 2023 | seekingalpha.comInMed Provides Business Update and Milestones for 2023January 10, 2023 | technews.tmcnet.comInMed Pharmaceuticals Secures $6M Via Private PlacementNovember 22, 2022 | msn.comInMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business UpdateSeptember 23, 2022 | benzinga.comInMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to MarketSeptember 13, 2022 | yahoo.comInMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to MarketSeptember 9, 2022 | finance.yahoo.comInMed Pharmaceuticals Inc.: InMed Announces Share Consolidation to Meet Nasdaq Listing CriteriaAugust 24, 2022 | finanznachrichten.deInMed Announces Share Consolidation to Meet Nasdaq Listing CriteriaAugust 23, 2022 | finance.yahoo.comInMed Pharmaceuticals Closes $5M Direct, Private Placement OfferingsJune 15, 2022 | apnews.comInMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq RulesJune 6, 2022 | finance.yahoo.comInMed Pharmaceuticals (INM): Health and Wellness Product LaunchesJune 1, 2022 | apnews.comInMed Pharmaceuticals Inc. (INM) Reports Q1 Loss, Lags Revenue EstimatesNovember 10, 2021 | nasdaq.comDeFi Will End Poorly Without Investor Protections, Gary Gensler SaysOctober 27, 2021 | benzinga.comInMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare CannabinoidsSeptember 13, 2021 | benzinga.comInMed Pharmaceuticals Inc. Enters Agreement For 'Transformative' Acquisition Of Leading Manufacturer Of Rare CannabinoidsSeptember 13, 2021 | benzinga.comWhere Do Blunts Come From? Who Was The First To Smoke One? Snoop Dogg Weighs InSeptember 7, 2021 | benzinga.comWhat You Need To Know About CBD HashSeptember 6, 2021 | benzinga.comLEGAL: New, Stunning Web Series Looks Into The First Country To Legalize Cannabis And The People Thriving Thanks To ItSeptember 4, 2021 | benzinga.comTerpene Producer Eybna Teams Up With Cannabis Brands Spherex And Orchid EssentialsSeptember 2, 2021 | benzinga.comCan Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find OutAugust 26, 2021 | benzinga.comHydrofarm Holdings Q2 Revenue Jumps 46.7% YoY To $133.8M, Raises Full Year Guidance Based On Important AcquisitionsAugust 15, 2021 | benzinga.comImmersive Cannabis Experience (Whatever That Is) To Debut In New York With A Social Justice TwistAugust 8, 2021 | benzinga.comSkymint Opens The Largest Cannabis Dispensary In Coldwater Michigan, Offering 60 Brands And Cool AtmosphereAugust 8, 2021 | benzinga.comCannabis Use In Aging Populations: What The Data Tells UsAugust 2, 2021 | benzinga.comWatch Global Go Analytics At The Benzinga Cannabis InsiderJuly 29, 2021 | benzinga.comFintech Co. POSaBit Teams Up With Springbig To Create POS Loyalty Program For Cannabis DispensariesJuly 28, 2021 | benzinga.comCannabis Influencer Jessica Golich To Release Book On Healing Through Plant MedicineJuly 24, 2021 | benzinga.com Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMLFF and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin IMLFF Media Mentions By Week IMLFF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMLFF News Sentiment▼0.640.60▲Average Medical News Sentiment IMLFF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMLFF Articles This Week▼10▲IMLFF Articles Average Week Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMLFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today AXIM News Today BRRGF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMLFF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
